OMER logo

OMER
Omeros Corp

11,436
Mkt Cap
$974.11M
Volume
1.52M
52W High
$17.65
52W Low
$2.95
PE Ratio
-27.07
OMER Fundamentals
Price
$13.53
Prev Close
$13.52
Open
$13.52
50D MA
$11.61
Beta
1.45
Avg. Volume
855,507.96
EPS (Annual)
-$0.0528
P/B
-8.00
Rev/Employee
$0.00
$1,325.99
Loading...
Loading...
News
all
press releases
Omeros (NASDAQ:OMER) Lowered to Hold Rating by Wall Street Zen
Wall Street Zen lowered Omeros from a "buy" rating to a "hold" rating in a research note on Sunday...
MarketBeat·10h ago
News Placeholder
More News
News Placeholder
D. Boral Capital Reiterates "Buy" Rating for Omeros (NASDAQ:OMER)
D. Boral Capital reissued a "buy" rating and issued a $36.00 price objective on shares of Omeros in a research note on Tuesday...
MarketBeat·5d ago
News Placeholder
Omeros (NASDAQ:OMER) Rating Increased to Buy at Wall Street Zen
Wall Street Zen raised shares of Omeros from a "hold" rating to a "buy" rating in a research report on Saturday...
MarketBeat·8d ago
News Placeholder
OMER Stock On Track For Best Week In Nearly 4 Months After Receiving Permanent Reimbursement Code For Treatment
Omeros said that the U.S. Centers for Medicare and Medicaid Services assigned a permanent J-code for its recently-approved treatment Yartemlea.
Stocktwits·9d ago
News Placeholder
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA (narsoplimab-wuug)
Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has assigned a permanent Healthcare Common Procedure Coding System (HCPCS) J-code for...
Business Wire·10d ago
News Placeholder
Omeros Corporation (NASDAQ:OMER) Given Average Recommendation of "Moderate Buy" by Brokerages
Omeros Corporation (NASDAQ:OMER - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six brokerages that are covering the firm, MarketBeat.com reports. One research analyst...
MarketBeat·14d ago
News Placeholder
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 266.7% in Omeros (OMER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·16d ago
News Placeholder
Omeros Corporation $OMER Shares Sold by Newbridge Financial Services Group Inc.
Newbridge Financial Services Group Inc. lowered its stake in shares of Omeros Corporation (NASDAQ:OMER - Free Report) by 74.5% in the fourth quarter, according to the company in its most recent...
MarketBeat·18d ago
News Placeholder
JPMorgan Chase & Co. Boosts Holdings in Omeros Corporation $OMER
JPMorgan Chase & Co. grew its position in Omeros Corporation (NASDAQ:OMER - Free Report) by 1,201.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 416,153 shares of the biopharmaceutical company's stock a...
MarketBeat·18d ago
News Placeholder
Omeros (NASDAQ:OMER) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen raised Omeros from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·22d ago
<
1
2
...
>

Latest OMER News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.